Do Stem Cell Injections Work for Knee Arthritis?
What the evidence and Malaysian regulations actually say about stem cell and PRP injections for knee osteoarthritis, and how to read the claims you are shown.
This page exists because the gap between what is advertised and what has been demonstrated is unusually wide here, and because a patient deciding whether to spend a large sum on an injection deserves to see the actual evidence rather than a brochure.
What the best available evidence says
The most reliable summary is a Cochrane systematic review published in April 2025, which pooled 25 randomised controlled trials involving 1,341 participants.
Compared with placebo, at six months:
- Pain improved by about 1.2 points on a 0 to 10 scale
- Function improved by about 14.2 points on a 0 to 100 scale
The review’s authors describe these as slight improvements. The certainty of the evidence was rated low for pain and function, and very low for quality of life, treatment success and adverse events.
The certainty was downgraded for specific, identifiable reasons: the preparations and doses used varied widely between trials, sample sizes were small, and the reviewers suspected publication bias arising from withdrawn trials.
The claim with no evidence behind it
The most common advertised claim is that these injections regenerate cartilage.
Not one of the 25 included trials assessed radiographic progression. No study looked at whether the joint structure changed. So there is no reliable evidence that stem cell injections regrow cartilage in an arthritic knee.
That is not the same as saying it is impossible. It means it has not been shown, and anyone telling you it will happen in your knee is going beyond what has been demonstrated.
Where Malaysian regulation actually sits
This is rarely explained on patient-facing pages, and it is important.
- Most stem cell therapies in Malaysia are characterised as experimental or research stage, not established routine clinical practice.
- They sit under the Ministry of Health guidelines for stem cell research and therapy.
- Research involving patients must be registered with the National Medical Research Registry.
- Centres offering human stem cell therapy require accreditation through the national stem cell research and ethics process.
- Cell and gene therapy products are regulated by the National Pharmaceutical Regulatory Agency as medicinal products requiring registration.
A telling detail: at least one prominent Malaysian provider states on its own website that its cell therapy protocol is undergoing product registration and is not yet approved for routine clinical use. That is an honest disclosure, and it is also a statement most patients would want explained to them before paying.
How to read what you are shown
Questions that separate a legitimate offer from a marketing claim:
- What exactly is being injected? Platelet-rich plasma, bone marrow aspirate concentrate, adipose-derived cells, or a manufactured cell product? These are not interchangeable.
- Under what regulatory approval is this being offered to me? Is it a registered clinical trial, an approved protocol, or neither?
- Is this centre accredited to provide human stem cell therapy?
- What outcome are you telling me to expect, and from which study? Ask for the citation.
- What happens if it does not work? Does it delay or complicate other treatment?
- What is the total cost, in writing, including repeat sessions?
If the answer to any of the first three is vague, that is the answer.
The honest comparison
For established knee osteoarthritis, the interventions with the strongest evidence remain unglamorous:
- Weight reduction, where relevant. The mechanical effect on the knee is substantial and it is the most underused intervention in the whole field.
- Structured strengthening and exercise therapy. Not rest.
- Simple analgesia, used sensibly.
- Corticosteroid injection for short-term flares.
- Joint replacement, when the joint is worn out and quality of life is the issue. It is one of the more reliable operations in medicine.
Cell-based injections are not a substitute for any of these, and they are not a way of avoiding a replacement that a knee genuinely needs.
What this page is not saying
It is not saying these treatments are worthless. It is saying that the evidence currently supports slight, uncertain symptomatic benefit and does not support structural regeneration, that in Malaysia they sit in a research rather than routine clinical space, and that you should be told both of those things before you decide.
If you want to discuss whether a cell-based option has any role in your case, that is a reasonable conversation to have with a surgeon who will also tell you when the answer is no.
Common questions
Is stem cell therapy for knees legal in Malaysia?
Most stem cell therapies in Malaysia are treated as experimental or research stage rather than established clinical practice. They fall under the Ministry of Health guidelines for stem cell research and therapy, research involving patients must be registered with the National Medical Research Registry, centres offering human stem cell therapy require accreditation, and cell and gene therapy products require registration with the National Pharmaceutical Regulatory Agency. Treatment outside an approved protocol or registered trial is not permitted.
Can stem cell injections regrow cartilage in my knee?
There is no reliable evidence that they do. A 2025 Cochrane review of 25 randomised trials found that not one of the included studies assessed whether joint structure changed on imaging. Regeneration is the most commonly advertised claim about these injections and it is the claim with the least evidence behind it.
So do they help with pain at all?
Slightly, on the current evidence, and with low certainty. The 2025 Cochrane review found pain improved by about 1.2 points on a 0 to 10 scale and function by about 14.2 points on a 0 to 100 scale at six months compared with placebo. The authors describe these as slight improvements and rate the certainty of evidence as low for pain and function and very low for quality of life and adverse events.
How is PRP different from stem cell therapy?
Platelet-rich plasma is prepared by spinning your own blood to concentrate platelets and growth factors. It contains no stem cells. Cell-based therapies involve harvesting and preparing cells, most often from bone marrow or fat, and are regulated far more tightly in Malaysia. They are different treatments with different evidence bases, different costs and different regulatory positions, and it is worth being clear which one you are being offered.
Why do clinics charge so much for it then?
Prices quoted online for knee stem cell treatment in Malaysia are unreliable and mostly recycled by directory sites without any stated source. Figures circulating for stem cell therapy generally, not specifically for knees, range widely and are internally inconsistent between countries. Ask for a written quotation from the provider, ask exactly what product is being used, and ask under what regulatory approval it is being offered.
References
Related reading
Stem Cell Therapy and PRP for the Knee
Cell-based and platelet injections for knee arthritis in Kuala Lumpur: what is offered, who it suits, what is involved, and how selection is decided.
Knee Osteoarthritis
What knee osteoarthritis is, how it is assessed and graded, what actually helps at each stage, and when a joint replacement becomes the sensible option.